Seres Therapeutics Q1 2018 Earnings Report

Total Revenue
$3.97M
Previous year: $3.02M
+31.7%
EPS
-$0.69
Previous year: -$0.63
+9.5%

Seres Therapeutics

Seres Therapeutics